Acute Peripheral Vertigo: Involvement of the Hemostatic System

International Tinnitus Journal

Volumn 9, Issue 2, 2003, Pages 124-129

  Fattori, Bruno ^a   Nacci, Andrea ^a   Ghilardi, P L PierLuigi ^a   Bruschini, Luca ^b   Matteucci, Fabio ^a   Ursino, Francesco ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Acute unilateral vestibular dysfunction; D dimer; Fibrinogen; Hemostatic system; Leukocyte count; Lipoprotein (a)

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN III; APOLIPOPROTEIN A; APOLIPOPROTEIN B; CARDIOLIPIN ANTIBODY; CHOLESTEROL; D DIMER; FIBRINOGEN; FOLIC ACID; HOMOCYSTEINE; LIPOPROTEIN A; PROTEIN C; PROTEIN S; TRIACYLGLYCEROL;

ACUTE PERIPHERAL VESTIBULOPATHY; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMOSTASIS; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MALE; MENIERE DISEASE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; TRIACYLGLYCEROL BLOOD LEVEL; VERTIGO; VESTIBULAR DISORDER; VIRUS INFECTION;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FOLIC ACID; FOLLOW-UP STUDIES; HEMOSTASIS; HUMANS; LEUKOCYTE COUNT; LIPOPROTEIN(A); MALE; MENIERE'S DISEASE; MIDDLE AGED; PROTHROMBIN TIME; VERTIGO;

EID: 1642454754     PISSN: 09465448     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Böhmer A. Acute Unilateral Peripheral Vestibulopathy. In RV Baloh, GM Halmagyi (eds), Disorders of the Vestibular System. Oxford: Oxford University Press, 1996:318-327.
2. Bamiou RA, Davies RA, McKee M, et al. The effect of severity of unilateral vestibular dysfunction on symptoms, disabilities and handicap in vertiginous patients. Clin Otolaryngol 24:31-38, 1999.
3. Andrews JC, Hoover LC, Lee RS, et al. Vertigo in the hyperviscosity syndrome. Otolaryngol Head Neck Surg 98:144-149, 1988.
4. Arbusow V, Schulz P, Strupp M, et al. Distribution of herpes simplex virus type 1 in human geniculate and vestibular ganglia: Implications for vestibular neuritis. Ann Neurol 46:416-419, 1999.
5. Baloh RW. Vertigo. Lancet 352:1841-1846, 1998.
6. De Ciccio M, Fattori B, Carpi A, et al. Vestibular disorders in primary thrombocytosis. J Otolaryngol 28:318-324, 1999.
7. Grad A, Baloh RW. Vertigo of vascular origin. Clinical and electronystagmographic features in 84 cases. Arch Neurol 46:281-284, 1989.
8. Gomez CR, Cruz-Flores S, Malkoff MD, et al. Isolated vertigo as a manifestation of vertebrobasilar ischemia. Neurology 47:94-97, 1996.
9. Lehrer JF, Poole DC, Seaman M, et al. Identification and treatment of metabolic abnormalities in patients with vertigo. Arch Intern Med 146:1497-1500, 1986.
10. Committee on Hearing and Equilibrium. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière's disease. Otolaryngol Head Neck Surg 113:181-185, 1995.
11. Asakura M, Kato I, Takahashi K, et al. Increased platelet aggregability in patients with vertigo, sudden deafness and facial palsy. Acta Otolaryngol Suppl (Stockh) 520:399-400, 1995.
12. Rybak LP. Metabolic disorders of the vestibular system. Otolaryngol Head Neck Surg 112:128-132, 1995.
13. Lowe GD, Rumley A, Woodward M, et al. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey: I. Br J Haematol 97:775-784, 1997.
14. Rylatt DB, Blake AS, Cottis LE. An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 31:767-778, 1983.
15. Sagripanti A, Carpi A. Natural anticoagulants, aging, and thromboembolism. Exp Gerontol 33:891-896, 1998.
16. Lowe GD, Rumley A. Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events. Thromb Haemost 82:667-672, 1999.
17. Kannel WB, Wolf PA, Castelli WP, et al. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 258:1183-1186, 1987.
18. Cressman MD, Heyka RJ, Paganini EP, et al. Lipoprotein (a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 86:475-482, 1992.